123 related articles for article (PubMed ID: 38469839)
21. Patient Perspectives: Propranolol for infantile hemangiomas.
Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
[No Abstract] [Full Text] [Related]
22. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
23. Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate.
Léauté-Labrèze C; Frieden I; Delarue A
Pediatr Dermatol; 2023 Mar; 40(2):261-264. PubMed ID: 36511888
[TBL] [Abstract][Full Text] [Related]
24. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
[TBL] [Abstract][Full Text] [Related]
25. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
26. Color Doppler Evaluation of Arterial Resistive Index in Infantile Hemangioma: A Useful Parameter to Monitor the Response to Oral Propranolol?
Parapatt GK; Oranges T; Paolantonio G; Ravà L; Giancristoforo S; Diociaiuti A; El Hachem M; Rollo M
Front Pediatr; 2021; 9():718135. PubMed ID: 34950614
[TBL] [Abstract][Full Text] [Related]
27. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
[TBL] [Abstract][Full Text] [Related]
28. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
29. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
30. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Propranolol Gel for Infantile Hemangioma: A Randomized, Double-Blind Study.
Rikihisa N; Takatsuka H; Suzuki T; Shiko Y; Kawasaki Y; Hanawa M; Ishii I; Mitsukawa N
Biol Pharm Bull; 2022 Jan; 45(1):42-50. PubMed ID: 34719577
[TBL] [Abstract][Full Text] [Related]
32. Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects.
Twist J; Chen A; Poffenberger P; Zinn Z
Pediatr Dermatol; 2022 Mar; 39(2):273-274. PubMed ID: 35178766
[TBL] [Abstract][Full Text] [Related]
33. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population.
Fu R; Zou Y; Wu Z; Jin P; Cheng J; Bai H; Huang M; Huan X; Yuan H
Sci Rep; 2023 Apr; 13(1):5956. PubMed ID: 37046020
[TBL] [Abstract][Full Text] [Related]
34. Safety assessment of propranolol for infantile hemangioma: a study in an Asian population.
Yu L; Wei L; Xu Z; Zhang B; Han X; Sun Y; Liu Y; Wang C; Qiu L; Xiu B; He R; Li L; Ma L
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):237-242. PubMed ID: 34918994
[TBL] [Abstract][Full Text] [Related]
35. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth.
Pam N; Kridin K; Khamaysi Z
Dermatol Ther; 2021 May; 34(3):e14936. PubMed ID: 33704861
[TBL] [Abstract][Full Text] [Related]
36. The impact of propranolol on the growth and development of children with proliferative infantile hemangioma during treatment.
Lin X; Wang T; Liu C; Deng L; Wang Q; Huang L; Gao J; Chen X; Chen S
Medicine (Baltimore); 2023 Jun; 102(23):e33998. PubMed ID: 37335657
[TBL] [Abstract][Full Text] [Related]
37. Propranolol Therapy for Problematic Infantile Hemangioma.
Ng M; Knuth C; Weisbrod C; Murthy A
Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
[TBL] [Abstract][Full Text] [Related]
38. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
Li XY; Wang Y; Jin L; Chen JR
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
[TBL] [Abstract][Full Text] [Related]
39. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
40. Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants.
Hengst M; Oelert M; Hoeger PH
Pediatr Dermatol; 2015; 32(6):802-7. PubMed ID: 26391729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]